Is High-Dose Extended-Release Buprenorphine Safe and Effective for Persons Who Use Fentanyl?  Springer SA.  JAMA Netw Open. 2025 Dec 1;8(12):e2547965. doi: 10.1001/jamanetworkopen.2025.47965. PMID: 41405890. https://jamanetwork.com/jour…

Bowielone (Buprenorphin-Naloxon) Hersteller: Etypharm https://www.ethypharm.de/product/bowielone/

Comparison of Extended-Release Buprenorphine Doses for Treating High-Risk Opioid Use: A Randomized Clinical Trial.  Shiwach R, Le Foll B, Alho H, Dunn KE, Strafford S, Zhao Y, Dobbins RL.  JAMA Netw Open. 2025 Dec 1;8(12):e2548043. doi…

Buprenorphine and Surface-based Brain Morphometry: Impacts on Cortical Thickness, Depth, and Gyrification in Patients with Opioid Use Disorder.  Ghosh A, Verma A, Kaur S, Ahuja CK, Nehra R, Singh P, Modi M, Kumaran S, Basu D.  Indian J P…

Reduced need for inpatient care following introduction of long-acting injectable buprenorphine.  Gauffin E, Marques Franca A, Pizzaro Ferrero E, Freij Z, Pihlflyckt I, Sandell M, Gedeon C, Zhang H, Andersson D, Tinghög G, Johansson Capusan A.&…

Practical guidance for navigating buprenorphine discontinuation.  Sonoda K, Hilmer AB, Bello JK.  Harm Reduct J. 2025 Dec 5. doi: 10.1186/s12954-025-01353-2. Epub ahead of print. PMID: 41350876. https://link.springer.com/article/10.1186…